Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy

Over the last decade, both early diagnosis and targeted therapy have improved the survival rates of many cancer patients. Most recently, immunotherapy has revolutionized the treatment options for cancers such as melanoma. Unfortunately, a significant portion of cancers (including lung and breast can...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Soundararajan, Rama, Fradette, Jared J., Konen, Jessica M., Moulder, Stacy, Zhang, Xiang, Gibbons, Don L., Varadarajan, Navin, Wistuba, Ignacio I., Tripathy, Debasish, Bernatchez, Chantale, Byers, Lauren A., Chang, Jeffrey T., Contreras, Alejandro, Lim, Bora, Parra, Edwin Roger, Roarty, Emily B., Wang, Jing, Yang, Fei, Barton, Michelle, Rosen, Jeffrey M., Mani, Sendurai A.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562947/
https://ncbi.nlm.nih.gov/pubmed/31137625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050714
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares